|
1.
|
HB El-SeragKL RudolphHepatocellular
carcinoma: epidemiology and molecular
carcinogenesisGastroenterology13225572576200710.1053/j.gastro.2007.04.06117570226
|
|
2.
|
H BlumHepatocellular carcinoma: therapy
and preventionWorld J Gastroenterol1173917400200516437707
|
|
3.
|
M CrampHBV + HCV = HCC?Gut451681691999
|
|
4.
|
Y SoiniSC ChiaWP BennettAn
aflatoxin-associated mutational hotspot at codon 249 in the p53
tumor suppressor gene occurs in hepatocellular carcinomas from
MexicoCarcinogenesis1710071012199610.1093/carcin/17.5.10078640905
|
|
5.
|
P BoffettaL MatisaneKA MundtLD
DellMeta-analysis of studies of occupational exposure to vinyl
chloride in relation to cancer mortalityScand J Work Environ
Health29220229200310.5271/sjweh.72512828392
|
|
6.
|
H TsukumaT HiyamaA OshimaA case-control
study of hepatocellular carcinoma in Osaka, JapanInt J
Cancer45231236199510.1002/ijc.2910450205
|
|
7.
|
F DonatoA TaggerU GelattiAlcohol and
hepatocellular carcinoma: the effect of lifetime intake and
hepatitis virus infections in men and womenAm J
Epidemiol155323333200210.1093/aje/155.4.32311836196
|
|
8.
|
S VoliniaGA CalinCG LiuA microRNA
expression signature of human solid tumors defines cancer gene
targetsProc Natl Acad Sci
USA10322572261200610.1073/pnas.051056510316461460
|
|
9.
|
N YanaiharaN CaplenE BowmanUnique micro
RNA molecular profiles in lung cancer diagnosis and prognosisCancer
Cell9189198200610.1016/j.ccr.2006.01.02516530703
|
|
10.
|
EJ LeeY GusevJ JiangExpression profiling
identifies microRNA signature in pancreatic cancerInt J
Cancer12010461054200710.1002/ijc.2239417149698
|
|
11.
|
Y MurakamiT YasudaK SaigoComprehensive
analysis of microRNA expression patterns in hepatocellular
carcinoma and non-tumorous
tissuesOncogene2525372545200610.1038/sj.onc.120928316331254
|
|
12.
|
A BudhuHL JiaM ForguesIdentification of
metastasis-related microRNAs in hepatocellular
carcinomaHepatology47897907200810.1002/hep.2216018176954
|
|
13.
|
H VarnhortU DrebberF SchulzeMicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinomaHepatology4712231232200810.1002/hep.2215818307259
|
|
14.
|
Y LaderioG CouchyC BalabaudMicroRNA
profiling in hepatocellular tumor is associated with clinical
features and oncogene/tumor suppressors gene
mutationsHepatology4719551963200810.1002/hep.2225618433021
|
|
15.
|
W LiL XieX HeDiagnostic and prognositic
implications of microRNAs in human hepatocellular carcinomaInt J
Cancer12316161622200810.1002/ijc.2369318649363
|
|
16.
|
S UraM HondaT YamashitaDifferential
microRNA expression between hapatitis B and hepatitis C leading
disease progression to hepatocellular
carcinomaHepatology4910981112200910.1002/hep.2274919173277
|
|
17.
|
S ToffaninY HoshidaA
LachenmayerMicroRNA-based classification of hepatocellular
carcinoma and oncogenic role of
miR-517aGastoenterology14016181628201110.1053/j.gastro.2011.02.00921324318
|
|
18.
|
M YasenH MizushimaK MogushiExpression of
Aurora B and alterative variant forms in hepatocellular carcinoma
and adjacent tissueCancer
Sci100472480200910.1111/j.1349-7006.2008.01068.x19134008
|
|
19.
|
L GramantieriF FornariE CallegariMicroRNA
involvement in hepatocellular carcinomaJ Cell Mol
Med1221892204200810.1111/j.1582-4934.2008.00533.x19120703
|
|
20.
|
RN AravalliCJ SteerNK CressmanMolecular
mechanisms of hepatocellular
carcinomaHepatology4820472063200810.1002/hep.22580
|
|
21.
|
J JiXW WangNew kids on the blockCancer
Biol Therapy816831690200910.4161/cbt.8.18.8898
|
|
22.
|
L LiangCM WongQ YingMicroRNA-125b
suppressed human liver cancer cell proliferation and metastasis by
directly targeting oncogene
LIN28BHepatology5217311740201010.1002/hep.2390420827722
|
|
23.
|
M OsakiF TakeshitaT OchiyaMicroRNAs as
biomarkers and therapeutic drugs in human
cancerBiomarkers13658670200810.1080/1354750080264657219096960
|
|
24.
|
J TakamizawaH KonishiK YanagisawaReduced
expression of the let-7 micro RNAs in human lung cancers in
association with shortened postoperative survivalCancer
Res6437533756200410.1158/0008-5472.CAN-04-063715172979
|
|
25.
|
M FabbriR GarzonA CimminoMicroRNA-29
family reverts aberrant methylation in lung cancer by targeting DNA
methyltransferases 3A and 3BProc Natl Acad Sci
USA1041580515810200710.1073/pnas.070762810417890317
|
|
26.
|
GT BommerI GerinY Fengp53-mediated
activation of miRNA34 candidate tumor-suppressor genesCurr
Biol1712981307200710.1016/j.cub.2007.06.06817656095
|
|
27.
|
M CrawfordE BrawnerK BattleMicroRNA-126
inhibits invasion in non-small cell lung carcinoma cell
linesBiochem Biophys Res
Commun373607612200810.1016/j.bbrc.2008.06.09018602365
|
|
28.
|
Y HayashitaH OsadaY TatematsuA
polycistronic microRNA cluster, miR-17-92, is overexpressed in
human lung cancers and enhances cell proliferationCancer
Res6596289632200510.1158/0008-5472.CAN-05-235216266980
|
|
29.
|
S VoliniaGA CalinCG LiuA microRNA
expression signature of human solid tumors defines cancer gene
targetsProc Natl Acad Sci
USA10322572261200610.1073/pnas.051056510316461460
|
|
30.
|
M GarofaloC QuintavalleG Di LevaMicroRNA
signatures of TRAIL resistance in human non-small cell lung
cancerOncogene2738453855200810.1038/onc.2008.618246122
|
|
31.
|
N YanaiharaN CaplenE BowmanUnique microRNA
molecular profiles in lung cancer diagnosis and prognosisCancer
Cell9189198200610.1016/j.ccr.2006.01.02516530703
|
|
32.
|
Z HuJ ChenT TianGenetic variants of miRNA
sequences and non-small cell lung cancer survivalJ Clin
Invest11826002608200818521189
|
|
33.
|
SL YuHY ChenGC ChangMicroRNA signature
predicts survival and relapse in lung cancerCancer
Cell134857200810.1016/j.ccr.2007.12.00818167339
|
|
34.
|
A MarkouEG TsarouchaL KaklamanisM FotinouV
GeogouliasES LianidouPrognostic value of mature microRNA-21 and
microRNA-205 overexpression in non-small cell lung cancer by
quantitative real-time RT-PCRClin
Chem5416961704200810.1373/clinchem.2007.10174118719201
|
|
35.
|
LX YanXF HuangQ ShaoMicroRNA miR-21
overexpression in human breast cancer is associated with advanced
clinical stage, lymph node metastasis and patient poor
prognosisRNA1423482360200810.1261/rna.103480818812439
|
|
36.
|
SH ChanCW WuAF LiCW ChiWC LinmiR-21
microRNA expression in human gastric carcinomas and its clinical
associationAnticancer Res28907911200818507035
|
|
37.
|
T SchepelerJT ReinertMS
OstenfeldDiagnostic and prognostic microRNAs in stage II colon
cancerCancer
Res6864166424200810.1158/0008-5472.CAN-07-611018676867
|
|
38.
|
G ChildsM FazzariG KungLow-level
expression of microRNAs let-7d and miR-205 are prognostic markers
of head and neck squamous cell carcinomaAm J
Pathol174736745200910.2353/ajpath.2009.08073119179615
|
|
39.
|
C RoldoE MissiagliaJP HaganMicroRNA
expression abnormalities in pancreatic endocrine and acinar tumors
are associated with distinctive pathologic features and clinical
behaviorJ Clin Oncol2446774684200610.1200/JCO.2005.05.5194
|
|
40.
|
G MarcucciMD RadmacherK MaharryMicroRNA
expression in cytogenetically normal acute myeloid leukemiaN Engl J
Med35819191928200810.1056/NEJMoa07425618450603
|
|
41.
|
GA CalinM FerracinA CimminoA microRNA
signature associated with prognosis and progression in chronic
lymphocytic leukemiaN Engl J
Med35317931801200510.1056/NEJMoa05099516251535
|
|
42.
|
L LuD KatsarosIA de la LongraisO SochircaH
YuHypermethylation of let-7a-3 in epithelial ovarian cancer is
associated with low insulin-like growth factor-II expression and
favorable prognosisCancer
Res671011710122200710.1158/0008-5472.CAN-07-254417974952
|
|
43.
|
Y GuoZ ChenL ZhangDistinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinomaCancer
Res682633200810.1158/0008-5472.CAN-06-441818172293
|
|
44.
|
SS ChimTK ShingEC HungDetection and
characterization of placental microRNAs in material plasmaClin
Chem54482490200810.1373/clinchem.2007.09797218218722
|
|
45.
|
S GiladE MeiriY YogevSerum microRNAs are
promising biomarkersPLoS
One3e3148200810.1371/journal.pone.000314818773077
|
|
46.
|
PS MitchelRA ParkinEM KrohCirculating
microRNAs as stable blood-based markers for cancer detectionProc
Natl Acad Sci
USA1051051310518200810.1073/pnas.080454910518663219
|
|
47.
|
CH LawrieCd CooperE BallabioJ ChiD
TramontiCS HattonAberrant expression of microRNA biosynthetic
pathways components is a common feature of haematological
malignancyBr J Hematol141672675200819298586
|
|
48.
|
R DiazJ SilvaJM GarciaDeregulated
expression of miR-106a predicts survival in human colon cancer
patientsGenes Chromosomes
Cancer47794802200810.1002/gcc.2058018521848
|
|
49.
|
K ScheeO FodstadK FlatmarkMicroRNAs as
biomarkers in colorectal cancerAm J
Patho17715921599201010.2353/ajpath.2010.10002420829435
|
|
50.
|
WKK WuCW LeeCH ChoD FanK WuJ YuJJY
SungMicroRNA dysregulation in gastric cancer: a new player enters
the gameOncogene2957615671201010.1038/onc.2010.35220802530
|
|
51.
|
J ZavadilH YeZ LiuProfiling and functional
analyses of microRNAs and their target gene products in human
uterine leiomyomasPLoS
One5e12362201010.1371/journal.pone.001236220808773
|
|
52.
|
MV IorioC PiovanCM CroceInterplay between
microRNAs and the epigenetic machinery: an intricate networkBoichim
Biophys Acta1799694701201010.1016/j.bbagrm.2010.05.00520493980
|
|
53.
|
N ValeriI VanniniF FaniniF CaloreB AdairM
FabbriEpigenetics, miRNAs, and human cancer: a new chapter in human
gene regulationMamm
Genome20573580200910.1007/s00335-009-9206-519697081
|
|
54.
|
A SchaeferM JungG KristiansenMicroRNAs and
cancer: current state and future perspectives in urologic
oncologyUrologic
Oncol28413201010.1016/j.urolonc.2008.10.02119117772
|
|
55.
|
R GarzonG MarcucciCM CroceTargeting
microRNAs in cancer: rationale, strategies and challengesNat Rev
Drug Discov9775789201010.1038/nrd317920885409
|
|
56.
|
GA CalinCG LiuC SevignaniMicroRNA
profiling reveals distinct signatures in B cell chronic lymphocytic
leukemiasProc Natl Acad Sci
USA1011175511760200410.1073/pnas.040443210115284443
|
|
57.
|
D BetelA KoppalP AngiusC SanderC
LeslieComprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sitesGenome
Biol11R90201010.1186/gb-2010-11-8-r9020799968
|
|
58.
|
JU KangSH KooKC KwonJW ParkJM KimGain at
chromosomal region 5p15.33, containing TERT, is the most frequent
genetic event in early stages of non-small cell lung cancerCancer
Genet
Cytogenet82111200810.1016/j.cancergencyto.2007.12.00418328944
|
|
59.
|
Y YamamotoY ChochiH MatuyamaGain of
5p15.33 is associated with progression of bladder
cancerOncology72132138200710.1159/000111132
|
|
60.
|
K YuK GanesanLK TanA precisely regulated
gene expression cassette potentially modulates metastasis and
survival in multiple solid cancersPLoS
Genet4e1000129200810.1371/journal.pgen.100012918636107
|
|
61.
|
D BodmerM EleveldE Kater-BaatsDisruption
of a novel MFS transporter gene, DIRC2, by a familial renal cell
carcinoma-associated t(2;3)(q35;q21)Hum Mol
Genet11641649200210.1093/hmg/11.6.64111912179
|
|
62.
|
Y WatanabeF YamasakiY KajiwaraExpression
of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in
astrocytic tumors: a novel approach of correlating malignancy grade
and prognosisJ
Neurooncol100449457201010.1007/s11060-010-0201-120455002
|
